|
1
|
Tauriello DV, Calon A, Lonardo E and
Batlle E: Determinants of metastatic competency in colorectal
cancer. Mol Oncol. 11:97–119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kurkjian C and Kummar S: Advances in the
treatment of metastatic colorectal cancer. Am J Ther. 16:412–420.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nie P, Hu W, Zhang T, Yang Y, Hou B and
Zou Z: Synergistic Induction of Erlotinib-Mediated Apoptosis by
Resveratrol in Human Non-Small-Cell Lung Cancer Cells by
Down-Regulating Survivin and Up-Regulating PUMA. Cell Physiol
Biochem. 35:2255–2271. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu HW and Cho WC: The emerging role of
miRNAs in combined cancer therapy. Expert Opin Biol Ther.
15:923–925. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao Y and Srivastava D: A developmental
view of microRNA function. Trends Biochem Sci. 32:189–197. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ao X, Nie P, Wu B, Xu W, Zhang T, Wang S,
Chang H and Zou Z: Decreased expression of microRNA-17 and
microRNA-20b promotes breast cancer resistance to taxol therapy by
upregulation of NCOA3. Cell Death Dis. 7:e24632016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zou Z, Luo X, Nie P, Wu B, Zhang T, Wei Y,
Wang W, Geng G, Jiang J and Mi Y: Inhibition of SRC-3 enhances
sensitivity of human cancer cells to histone deacetylase
inhibitors. Biochem Biophys Res Commun. 478:227–233. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Amirkhah R, Schmitz U, Linnebacher M,
Wolkenhauer O and Farazmand A: MicroRNA-mRNA interactions in
colorectal cancer and their role in tumor progression. Genes
Chromosomes Cancer. 54:129–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fiore R, Siegel G and Schratt G: MicroRNA
function in neuronal development, plasticity and disease. Biochim
Biophys Acta. 1779:471–478. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu DR, Huang S, Long ZJ, Chen JJ, Zou ZZ,
Li J, Lin DJ and Liu Q: Inhibition of mitotic kinase Aurora
suppresses Akt-1 activation and induces apoptotic cell death in
all-trans retinoid acid-resistant acute promyelocytic leukemia
cells. J Transl Med. 9:742011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang Q, Wang Y, Hao Y, Juan L, Teng M,
Zhang X, Li M, Wang G and Liu Y: miR2Disease: A manually curated
database for microRNA deregulation in human disease. Nucleic Acids
Res. 37(Database): D98–D104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao J, Zou Z, Gao J, Zhang H, Lin Z, Zhang
Y, Luo X, Liu C, Xie J and Cai C: Increased expression of HMGB3: A
novel independent prognostic marker of worse outcome in patients
with esophageal squamous cell carcinoma. Int J Clin Exp Pathol.
8:345–352. 2015.PubMed/NCBI
|
|
13
|
Zhu J, Zou Z, Nie P, Kou X, Wu B, Wang S,
Song Z and He J: Downregulation of microRNA-27b-3p enhances
tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1
expression. Cell Death Dis. 7:e24542016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luo X, Yao J, Nie P, Yang Z, Feng H, Chen
P, Shi X and Zou Z: FOXM1 promotes invasion and migration of
colorectal cancer cells partially dependent on HSPA5
transactivation. Oncotarget. 7:26480–26495. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mi YJ, Geng GJ, Zou ZZ, Gao J, Luo XY, Liu
Y, Li N, Li CL, Chen YQ, Yu XY, et al: Dihydroartemisinin inhibits
glucose uptake and cooperates with glycolysis inhibitor to induce
apoptosis in non-small cell lung carcinoma cells. PLoS One.
10:e01204262015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen P, Luo X, Nie P, Wu B, Xu W, Shi X,
Chang H, Li B, Yu X and Zou Z: CQ synergistically sensitizes human
colorectal cancer cells to SN-38/CPT-11 through lysosomal and
mitochondrial apoptotic pathway via p53-ROS cross-talk. Free Radic
Biol Med. 104:280–297. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lou YF, Zou ZZ, Chen PJ, Huang GB, Li B,
Zheng DQ, Yu XR and Luo XY: Combination of gefitinib and DNA
methylation inhibitor decitabine exerts synergistic anti-cancer
activity in colon cancer cells. PLoS One. 9:e977192014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nita ME, Nagawa H, Tominaga O, Tsuno N,
Fujii S, Sasaki S, Fu CG, Takenoue T, Tsuruo T and Muto T:
5-Fluorouracil induces apoptosis in human colon cancer cell lines
with modulation of Bcl-2 family proteins. Br J Cancer. 78:986–992.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zou Z-Z, Nie P-P, Li Y-W, Hou B-X, Li R,
Shi X-P, Ma Z-K, Han B-W and Luo X-Y: Synergistic induction of
apoptosis by salinomycin and gefitinib through lysosomal and
mitochondrial dependent pathway overcomes gefitinib resistance in
colorectal cancer. Oncotarget. 8:22414–22432. 2015.
|
|
21
|
Zou Z, Yuan Z, Zhang Q, Long Z, Chen J,
Tang Z, Zhu Y, Chen S, Xu J, Yan M, et al: Aurora kinase A
inhibition-induced autophagy triggers drug resistance in breast
cancer cells. Autophagy. 8:1798–1810. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou W, Xu J, Gelston E, Wu X, Zou Z, Wang
B, Zeng Y, Wang H, Liu A, Xu L, et al: Inhibition of Bcl-xL
overcomes polyploidy resistance and leads to apoptotic cell death
in acute myeloid leukemia cells. Oncotarget. 6:21557–21571.
2015.PubMed/NCBI
|
|
23
|
Zhang H, Tang J, Li C, Kong J, Wang J, Wu
Y, Xu E and Lai M: miR-22 regulates 5-FU sensitivity by inhibiting
autophagy and promoting apoptosis in colorectal cancer cells.
Cancer Lett. 356(2 Pt B): 1–790. 2015.
|
|
24
|
Czabotar PE, Colman PM and Huang DC: Bax
activation by Bim? Cell Death Differ. 16:1187–1191. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Borralho PM, Kren BT, Castro RE, da Silva
IB, Steer CJ and Rodrigues CM: MicroRNA-143 reduces viability and
increases sensitivity to 5-fluorouracil in HCT116 human colorectal
cancer cells. FEBS J. 276:6689–6700. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu S, Fesler A and Ju J: Implications of
Circadian Rhythm Regulation by microRNAs in Colorectal Cancer.
Cancer Transl Med. 2:1–6. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Marani M, Tenev T, Hancock D, Downward J
and Lemoine NR: Identification of novel isoforms of the BH3 domain
protein Bim which directly activate Bax to trigger apoptosis. Mol
Cell Biol. 22:3577–3589. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nishida N, Yamashita S, Mimori K, Sudo T,
Tanaka F, Shibata K, Yamamoto H, Ishii H, Doki Y and Mori M:
MicroRNA-10b is a prognostic indicator in colorectal cancer and
confers resistance to the chemotherapeutic agent 5-fluorouracil in
colorectal cancer cells. Ann Surg Oncol. 19:3065–3071. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim SA, Kim I, Yoon SK, Lee EK and Kuh HJ:
Indirect modulation of sensitivity to 5-fluorouracil by microRNA-96
in human colorectal cancer cells. Arch Pharm Res. 38:239–248. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou J, Zhou Y, Yin B, Hao W, Zhao L, Ju W
and Bai C: 5-Fluorouracil and oxaliplatin modify the expression
profiles of microRNAs in human colon cancer cells in vitro. Oncol
Rep. 23:121–128. 2010.PubMed/NCBI
|
|
31
|
Qian X, Yu J, Yin Y, He J, Wang L, Li Q,
Zhang LQ, Li CY, Shi ZM, Xu Q, et al: MicroRNA-143 inhibits tumor
growth and angiogenesis and sensitizes chemosensitivity to
oxaliplatin in colorectal cancers. Cell Cycle. 12:1385–1394. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hansen TF, Sørensen FB, Lindebjerg J and
Jakobsen A: The predictive value of microRNA-126 in relation to
first line treatment with capecitabine and oxaliplatin in patients
with metastatic colorectal cancer. BMC Cancer. 12:832012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tong JL, Zhang CP, Nie F, Xu XT, Zhu MM,
Xiao SD and Ran ZH: MicroRNA 506 regulates expression of PPAR alpha
in hydroxycamptothecin-resistant human colon cancer cells. FEBS
Lett. 585:3560–3568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Boni V, Zarate R, Villa JC, Bandrés E,
Gomez MA, Maiello E, Garcia-Foncillas J and Aranda E: Role of
primary miRNA polymorphic variants in metastatic colon cancer
patients treated with 5-fluorouracil and irinotecan.
Pharmacogenomics J. 11:429–436. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu Y, Peng Q, Lin Y, Zou L, Shen P, Chen
F, Min M, Shen L, Chen J and Shen B: Identification of biomarker
microRNAs for predicting the response of colorectal cancer to
neoadjuvant chemoradiotherapy based on microRNA regulatory network.
Oncotarget. 8:2233–2248. 2017.PubMed/NCBI
|
|
36
|
Zhang Y, Yu J, Liu H, Ma W, Yan L, Wang J
and Li G: Novel Epigenetic CREB-miR-630 Signaling Axis Regulates
Radiosensitivity in Colorectal Cancer. PLoS One. 10:e01338702015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang XD, Xu XH, Zhang SY, Wu Y, Xing CG,
Ru G, Xu HT and Cao JP: Role of miR-100 in the radioresistance of
colorectal cancer cells. Am J Cancer Res. 5:545–559.
2015.PubMed/NCBI
|
|
38
|
Ma W, Yu J, Qi X, Liang L, Zhang Y and
Ding Y, Lin X, Li G and Ding Y: Radiation-induced microRNA-622
causes radioresistance in colorectal cancer cells by
down-regulating Rb. Oncotarget. 6:15984–15994. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zheng L, Zhang Y, Liu Y, Zhou M, Lu Y,
Yuan L, Zhang C, Hong M, Wang S and Li X: MiR-106b induces cell
radioresistance via the PTEN/PI3K/AKT pathways and p21 in
colorectal cancer. J Transl Med. 13:2522015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yin E, Nelson DO, Coleman MA, Peterson LE
and Wyrobek AJ: Gene expression changes in mouse brain after
exposure to low-dose ionizing radiation. Int J Radiat Biol.
79:759–775. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang Y, Zheng L, Huang J, Gao F, Lin X,
He L, Li D, Li Z, Ding Y and Chen L: MiR-124 Radiosensitizes human
colorectal cancer cells by targeting PRRX1. PLoS One. 9:e939172014.
View Article : Google Scholar : PubMed/NCBI
|
